Web Analytics Made Easy - Statcounter
What
image
  • international trade & development
  • pharmaceuticals
Where
image
image

SPARC (NSE: SPARC; BSE: 532872) is a biopharmaceutical company continuously innovating new therapies in oncology, neurodegeneration, and immunology.

SPARC’s value proposition lies in our brick-and-mortar infrastructure to effectively translate therapies from the bench, through clinical studies, to regulatory approval. This engine has resulted in approval of two NDAs. Our approved products are marketed by our commercial partners in the US, China, and India.

We are 400+ strong team spread across three global locations, with a vibrant research community of 350+ scientists working on a robust pipeline of clinical and preclinical programs. Our teams’ strengths span the R&D spectrum: small and large molecule drug discovery; CMC development; preclinical translation (including NDA-enabling toxicology); and clinical development and operations.

All of this makes SPARC unique among other small biopharma companies, especially single-asset or single-therapy focused companies.

We continue to build and strengthen our innovation engine with emphases on strong scientific execution, high value analytics, and aggressive portfolio management, to redefine patient care in areas of unmet need.

Company’s Keywords:

Q How Many Employees Does This Company Have?

620

Q Which Industry Does This Company Belong To?

pharmaceuticals

Q What Is the Annual Income?

35214000

Q What Is the Technology of All the Company’s Website?

Cloudflare DNS, Outlook, CloudFlare Hosting, Google Font API, Mobile Friendly, Bootstrap Framework, McAfee

Q What Year Was the Company Founded?

2007

Rate us and Write a Review

Your Rating for this listing

angry
crying
sleeping
smily
cool
Browse

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image